Respiratory Flashcards
COPD
Chronic bronchitis
Emphysema
COPD is a common respiratory condition involving the airways and characterised by airflow limitation
Exacerbations and comorbidities contribute to the overall severity in individual patients
Signs and symptoms of emphysema
Known as “pink puffer” due to difficulty reathing but are well perfused
Dyspnea
Productive cough
Wheezing
Chest tightness
Pure emphysema patients:
Barrel Chest
Muscle wasting
Pursed lips
Signs and symptoms of chronic bronchitis
“blue bloaters” because they are usually synosed
Dyspnea
Productive cough
Wheezing
Chest tightness
Pure chronic bronchitis:
Peripheral Oedema
Raised JVP due to potential right-sided heart failure
Pathophysiology of emphysema
Pure emphysema affects alveoli. Alveoli are covered in elastic fibers allowing alvoli to expand and recoil back pushing air out as we exhale
However in emphysema what we see is a loss of elastic fibers and decrease in surgace area of the alveoli, this could lead to collapsed alveoli
Can also get air trapping which is where air is still trapped in the alveoli as we exhale because the recoil mechanism isn’t working
Pathophysiology of chronic bronchitis
Problems along bronchioles. In chronic bronchitis you have smooth muscle hypertrophy and contraction as well as mucus hypersecretion. Leads to difficulty breathing
Risk Factors for COPD
Investigations for COPD
1.Spirometry: FEV1/FVC ratio >70%
When evaluationg a patient with possible COPD spirometry is performed. Spirometry is performed pre and post bronchodilator administration to determine whether airflow limitation is present, partial or fully restrictive
2.X-Ray:
-Flattened diaphragm
-Hyperexpansion -> Hyperinflation
- Pulse oximetry -> check for O2 sat
Decreased O2 -> Hypoxemia - FBC -> check for amaemia
- Arterial blood gas
Is it respiratory acidosis/alkalosis
Late Stage COPD usually decreased O2 and increased CO2 - ECG
Check for heart involvement
Rule out MI, heart Failure
Diagnosis of COPD
Management of COPD
- Smoking Cessation
- Vaccination
- Bronchodilators: B2 agonists/anticholinergic. Short/Long acting
- Corticosteroids: inhaled glucocorticosteroids used in combination with long acting bronchodilators -> corticosteroids are not used alone
- Pulmonary rehab
- Oxygen therapy: for chronic COPD who has hypoxemia
Classification of COPD
Assessment of severity of condition is based on three factors:
1.Severity of symtpoms
2.Spirometry
3.Risk of exacerbations
Using the three features -> COPD classification -> Gold guidelines for COPD management
What is asthma
Chronic inflammatory disease affecting the lower airway, characterised by hyperresponsiveness and bronchospasm leading to airway narrowing
Pathophysiology of asthma
Triggers:
Allergic: pollen, pets
Nonallergic: smoking, perfumes
Trigger taken by dendritic cell and presented to T-helper 2 cell. TH2 cells produce IL-4, IL-13 (cause plasma cells to release IgE. IgE activated mast cells to cause degranulation. Granules include histamine leukotriene, prostaglandin- type 1 hypersensitivty reaction -> bronchospasm, increased mucus production, oedema. This narrows airway and produces symptoms) and IL-5 (leads to activation of eosinophils which release more cytokines and leukotriene contibuting to symptoms as well.
Acute exacerbation of asthma vs long term
Acute: Reversible
Long term: remodelling. Irreversible
1. Subepithelial fibrosis
2. Smooth muscle hypertrophy
3. Increased mucus production
4. Increased vascuarity
Causes/Risk Factors of asthma
Signs and symptoms of asthma
Recurrent episodes:
1.Dyspnea
2.Wheezing
3.Chest tightness
4.Coughing
Often worse at night or in response to exercise/cold air
Associated:
Anxiety
Obstructive sleep apnea
GORD
Complications of asthma
Remodelling: COPD
Increased rates of anxiety and depression
Asthma can be lethal
Diagnosis of asthma
Acute Exacerbation severity (mnemonic)
A: Altered consciousness
Arrhythmia
C: Cyanosis. PaCO2
H: Hypotension/Hypoxia
E: Exhaustion
S: Silent chest
T: Threatening PEF (<=33% Of best)
Treatment for asthma
No definitve cure. Stepwise approach
Long term: Assess-> Adjust -> Review (Repeat)
1.Short acting B2 agonist (salbutamol). SABA used as a reliever in most steps
2.Low dose inhaled corticosteroids
3.Long acting B2 agonist (salmeterol) + increasing ICS doses
4.Leukotriene receptor antagonists (montelukast)
5.Long acting anti-muscarinic (tiotropium)
6.Targeted Therapy: Anti IgE (omalizumab). Anti IL4/IL5
Acute Exacerbations:
1. O2
2. Nebulisers: Salbutamol, ipratropium
3. Systemic corticosteroids: prednisolone
If unresolved:
4. Mechanical sulfate
5. Mechanical Ventilation
Viral infections are common triggers, antibiotics given if baterial
Lung Infections
TB
Pneumonia
What is tuberculosis
Bacterial infection caused by “mycobacterium tuberculosis complex”
Characterised by the presence of chronic granulomatous inflammatory reaction
99% Mycobacterium tuberculosis
Mycoacterium bovis: Oropharyngeal & Intestinal TB
Mycobacterium Tuberculosis
Obligate aerobe
Intracellular pathogen
Grow very slowly
Lipid rich cell wall - mycolic acid
Do not stain with gram stain
Mannose capped glycolipids to bind macrophages
Able to survive and multiply inside macrophages by avoiding lysosomal killing
Acid & alcohol fast bacilli - do not decolourise with acid or alcohol when stained with Ziehl Nielson stain
Sensitive to: Heat, UV light, alcohol fermaldehyde, gluteraldehyde
Primarily infects lungs, intestine, bone, liver, kidney, brain, eye
Risk Factors for TB
HIV infection: serious risk factor for TB
Alcoholism
Diabetes Mellitus
Recent surgery
Immunosuppressive therapy - corticosteroids
Workers in healthcare facilites
Types of TB
2 types:
1. Primary TB - in non-sensitised hosts
2. Post-Primary (secondary) TB - in sensitised hosts
Spectrum of disease based on the immune response of the host
- Active TB - multiplying bacilli
-Pulmonary TB
-Extra pulmonary TB
-Miliary TB - Blood stream spread wih high bacillary load
2.Latent TB -Dormant bacilli
Pathogenesis of Primary Pulmonary TB
Primary Pulmonary TB - In non sensitised hosts
Inhalation of M.tuberculosis -> Bacilli get lodged in the “upper part of the lower lobe, or lower part of the upper lobe sub pleurally” -> Bacteria are engulfed by the alveolar macrophages -> Survive inside the macrophage -> Unchecked bacillary proliferation (first 3 weeks) -> Bacgeria spread via lymphatics & blood stream to the other parts of the body -> Asymptomatic/Mild flu like illness
- Macrophage response -> Inflammation (Ghon’s focus)
- Bacilli are taken to the lymph nodes via lymphatics -> Inflammation at the lymph nodes
- Bacilli in lymph nodes -> Macrophage presents processed Mycobacterual antigens to CD4 T cells (> 3 weeks) -> T cells become T helper cells -> T helper cells secrete cytokines acivating macrophages
- Activated macrophages:
1: Kill the bacilli by varous mechanisms: ROS, RNS, proteases -> Most bacilli get killed, but some may remain dormant for several years.
2: Secrete cytokines (TNF) -> Recruit more macrophages/Macrophage activation/Differentiation of macrophages into epithelioid cells -> formuation of granulomas
Possible outcomes of Primary Pulmonary TB
Control of the infection in immunocompetent hosts with healed lesions
Granuloma -> Heals by fibrosis -> Dystrophic calcification -> Ossification
Some bacilli may remain dormant
In immunocompromised patients: Primary pulmonary TB -> Progressive pulmonary TB
Progressive Primary TB
Most often resembles an acute bacterial pneumonia
Pleural effusion
Lung collapse
Cavitation is rare
Lower and middle lobe consolidation
Dissemintation of bacilli via lymphatics & blood stream -> Miliary TB/TB meningitis/TB lymphadenitis/TB spine